Valproic acid intensifies epileptiform activity in the hippocampal pyramidal neurons

The effects of large concentrations of valproic acid (VPA) on veratridine-induced epileptiform activity (veratridine model) were investigated in rat hippocampal CA1 pyramidal neurons. Studies were performed on the veratridine model in rat brain slices using conventional electrophysiological intracel...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Neuroscience research 1999-12, Vol.35 (4), p.299-307
Hauptverfasser: Otoom, Sameer A, Alkadhi, Karim A
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 307
container_issue 4
container_start_page 299
container_title Neuroscience research
container_volume 35
creator Otoom, Sameer A
Alkadhi, Karim A
description The effects of large concentrations of valproic acid (VPA) on veratridine-induced epileptiform activity (veratridine model) were investigated in rat hippocampal CA1 pyramidal neurons. Studies were performed on the veratridine model in rat brain slices using conventional electrophysiological intracellular techniques. Large concentrations of VPA (5 mM or more) enhanced rather than inhibited epileptiform activity induced by veratridine. During the proepileptic phase of VPA, a membrane depolarization accompanied by a decrease in membrane input resistance were evident. The voltage-dependent proepileptic effect of VPA was blocked by tetrodotoxin (TTX; 100 nM) but not by the calcium channel blockers, diltiazem (5 μM) or ω-conotoxin GVIA (5 μM). VPA did not induce a proepileptic effect when it was superfused at high concentration (0.5–10 mM) on sodium channel-independent models such as the bicuculline or magnesium-free artificial cerebrospinal fluid. Large concentrations of VPA had no significant effect on untreated neurons. The VPA-enhanced veratridine bursting is probably related to the reported proepileptic activities observed in patients taking high doses of this drug. These data also suggest the involvement of sodium channels in the proepileptic effect of VPA.
doi_str_mv 10.1016/S0168-0102(99)00099-1
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_69385497</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0168010299000991</els_id><sourcerecordid>69385497</sourcerecordid><originalsourceid>FETCH-LOGICAL-c390t-23c623d2b8c55a54fa2056c1f39ce2a2e304c3330c275b65d5b08964be95fbb33</originalsourceid><addsrcrecordid>eNqFkEtLw0AQgBdRbK3-BCUn0UN0H9k0exIpvqDgwep12WwmdCQvd5NC_73bRsSbl5mB-WaG-Qg5Z_SGUZbevoWQxZRRfqXUNaVUqZgdkCnL5jzOGGOHZPqLTMiJ958BEioRx2TCaMrmgrMpWX2YqnMt2shYLCJsemg8lgg-gg4r6HosW1eHbo8b7LeBiPo1RGvsutaaujNV1G2dqbEIVQODaxt_So5KU3k4-8kz8v74sFo8x8vXp5fF_TK2QtE-5sKmXBQ8z6yURial4VSmlpVCWeCGg6CJFUJQy-cyT2Uhc5qpNMlByTLPhZiRy3Fv-OBrAN_rGr2FqjINtIPXqRKZTNQ8gHIErWu9d1DqzmFt3FYzqnc69V6n3rnSSum9Ts3C3MXPgSGvofgzNfoLwN0IQHhzg-C0twiNhQId2F4XLf5z4hv144WE</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>69385497</pqid></control><display><type>article</type><title>Valproic acid intensifies epileptiform activity in the hippocampal pyramidal neurons</title><source>MEDLINE</source><source>Access via ScienceDirect (Elsevier)</source><creator>Otoom, Sameer A ; Alkadhi, Karim A</creator><creatorcontrib>Otoom, Sameer A ; Alkadhi, Karim A</creatorcontrib><description>The effects of large concentrations of valproic acid (VPA) on veratridine-induced epileptiform activity (veratridine model) were investigated in rat hippocampal CA1 pyramidal neurons. Studies were performed on the veratridine model in rat brain slices using conventional electrophysiological intracellular techniques. Large concentrations of VPA (5 mM or more) enhanced rather than inhibited epileptiform activity induced by veratridine. During the proepileptic phase of VPA, a membrane depolarization accompanied by a decrease in membrane input resistance were evident. The voltage-dependent proepileptic effect of VPA was blocked by tetrodotoxin (TTX; 100 nM) but not by the calcium channel blockers, diltiazem (5 μM) or ω-conotoxin GVIA (5 μM). VPA did not induce a proepileptic effect when it was superfused at high concentration (0.5–10 mM) on sodium channel-independent models such as the bicuculline or magnesium-free artificial cerebrospinal fluid. Large concentrations of VPA had no significant effect on untreated neurons. The VPA-enhanced veratridine bursting is probably related to the reported proepileptic activities observed in patients taking high doses of this drug. These data also suggest the involvement of sodium channels in the proepileptic effect of VPA.</description><identifier>ISSN: 0168-0102</identifier><identifier>EISSN: 1872-8111</identifier><identifier>DOI: 10.1016/S0168-0102(99)00099-1</identifier><identifier>PMID: 10617321</identifier><language>eng</language><publisher>Ireland: Elsevier Ireland Ltd</publisher><subject>Action Potentials - drug effects ; Action Potentials - physiology ; Animals ; Bicuculline ; Bicuculline - pharmacology ; Disease Models, Animal ; Epilepsy - physiopathology ; GABA Antagonists - pharmacology ; Hippocampus ; Hippocampus - drug effects ; Hippocampus - physiopathology ; Magnesium-free artificial cerebrospinal fluid (ACSF) ; Male ; Proepileptic ; Pyramidal Cells - drug effects ; Pyramidal Cells - physiopathology ; Rats ; Rats, Sprague-Dawley ; Sodium Channels - drug effects ; Sodium Channels - physiology ; Valproic acid ; Valproic Acid - pharmacology ; Veratridine</subject><ispartof>Neuroscience research, 1999-12, Vol.35 (4), p.299-307</ispartof><rights>1999 Elsevier Science Ireland Ltd</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c390t-23c623d2b8c55a54fa2056c1f39ce2a2e304c3330c275b65d5b08964be95fbb33</citedby><cites>FETCH-LOGICAL-c390t-23c623d2b8c55a54fa2056c1f39ce2a2e304c3330c275b65d5b08964be95fbb33</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://dx.doi.org/10.1016/S0168-0102(99)00099-1$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,780,784,3550,27924,27925,45995</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/10617321$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Otoom, Sameer A</creatorcontrib><creatorcontrib>Alkadhi, Karim A</creatorcontrib><title>Valproic acid intensifies epileptiform activity in the hippocampal pyramidal neurons</title><title>Neuroscience research</title><addtitle>Neurosci Res</addtitle><description>The effects of large concentrations of valproic acid (VPA) on veratridine-induced epileptiform activity (veratridine model) were investigated in rat hippocampal CA1 pyramidal neurons. Studies were performed on the veratridine model in rat brain slices using conventional electrophysiological intracellular techniques. Large concentrations of VPA (5 mM or more) enhanced rather than inhibited epileptiform activity induced by veratridine. During the proepileptic phase of VPA, a membrane depolarization accompanied by a decrease in membrane input resistance were evident. The voltage-dependent proepileptic effect of VPA was blocked by tetrodotoxin (TTX; 100 nM) but not by the calcium channel blockers, diltiazem (5 μM) or ω-conotoxin GVIA (5 μM). VPA did not induce a proepileptic effect when it was superfused at high concentration (0.5–10 mM) on sodium channel-independent models such as the bicuculline or magnesium-free artificial cerebrospinal fluid. Large concentrations of VPA had no significant effect on untreated neurons. The VPA-enhanced veratridine bursting is probably related to the reported proepileptic activities observed in patients taking high doses of this drug. These data also suggest the involvement of sodium channels in the proepileptic effect of VPA.</description><subject>Action Potentials - drug effects</subject><subject>Action Potentials - physiology</subject><subject>Animals</subject><subject>Bicuculline</subject><subject>Bicuculline - pharmacology</subject><subject>Disease Models, Animal</subject><subject>Epilepsy - physiopathology</subject><subject>GABA Antagonists - pharmacology</subject><subject>Hippocampus</subject><subject>Hippocampus - drug effects</subject><subject>Hippocampus - physiopathology</subject><subject>Magnesium-free artificial cerebrospinal fluid (ACSF)</subject><subject>Male</subject><subject>Proepileptic</subject><subject>Pyramidal Cells - drug effects</subject><subject>Pyramidal Cells - physiopathology</subject><subject>Rats</subject><subject>Rats, Sprague-Dawley</subject><subject>Sodium Channels - drug effects</subject><subject>Sodium Channels - physiology</subject><subject>Valproic acid</subject><subject>Valproic Acid - pharmacology</subject><subject>Veratridine</subject><issn>0168-0102</issn><issn>1872-8111</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1999</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqFkEtLw0AQgBdRbK3-BCUn0UN0H9k0exIpvqDgwep12WwmdCQvd5NC_73bRsSbl5mB-WaG-Qg5Z_SGUZbevoWQxZRRfqXUNaVUqZgdkCnL5jzOGGOHZPqLTMiJ958BEioRx2TCaMrmgrMpWX2YqnMt2shYLCJsemg8lgg-gg4r6HosW1eHbo8b7LeBiPo1RGvsutaaujNV1G2dqbEIVQODaxt_So5KU3k4-8kz8v74sFo8x8vXp5fF_TK2QtE-5sKmXBQ8z6yURial4VSmlpVCWeCGg6CJFUJQy-cyT2Uhc5qpNMlByTLPhZiRy3Fv-OBrAN_rGr2FqjINtIPXqRKZTNQ8gHIErWu9d1DqzmFt3FYzqnc69V6n3rnSSum9Ts3C3MXPgSGvofgzNfoLwN0IQHhzg-C0twiNhQId2F4XLf5z4hv144WE</recordid><startdate>19991230</startdate><enddate>19991230</enddate><creator>Otoom, Sameer A</creator><creator>Alkadhi, Karim A</creator><general>Elsevier Ireland Ltd</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>19991230</creationdate><title>Valproic acid intensifies epileptiform activity in the hippocampal pyramidal neurons</title><author>Otoom, Sameer A ; Alkadhi, Karim A</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c390t-23c623d2b8c55a54fa2056c1f39ce2a2e304c3330c275b65d5b08964be95fbb33</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1999</creationdate><topic>Action Potentials - drug effects</topic><topic>Action Potentials - physiology</topic><topic>Animals</topic><topic>Bicuculline</topic><topic>Bicuculline - pharmacology</topic><topic>Disease Models, Animal</topic><topic>Epilepsy - physiopathology</topic><topic>GABA Antagonists - pharmacology</topic><topic>Hippocampus</topic><topic>Hippocampus - drug effects</topic><topic>Hippocampus - physiopathology</topic><topic>Magnesium-free artificial cerebrospinal fluid (ACSF)</topic><topic>Male</topic><topic>Proepileptic</topic><topic>Pyramidal Cells - drug effects</topic><topic>Pyramidal Cells - physiopathology</topic><topic>Rats</topic><topic>Rats, Sprague-Dawley</topic><topic>Sodium Channels - drug effects</topic><topic>Sodium Channels - physiology</topic><topic>Valproic acid</topic><topic>Valproic Acid - pharmacology</topic><topic>Veratridine</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Otoom, Sameer A</creatorcontrib><creatorcontrib>Alkadhi, Karim A</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Neuroscience research</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Otoom, Sameer A</au><au>Alkadhi, Karim A</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Valproic acid intensifies epileptiform activity in the hippocampal pyramidal neurons</atitle><jtitle>Neuroscience research</jtitle><addtitle>Neurosci Res</addtitle><date>1999-12-30</date><risdate>1999</risdate><volume>35</volume><issue>4</issue><spage>299</spage><epage>307</epage><pages>299-307</pages><issn>0168-0102</issn><eissn>1872-8111</eissn><abstract>The effects of large concentrations of valproic acid (VPA) on veratridine-induced epileptiform activity (veratridine model) were investigated in rat hippocampal CA1 pyramidal neurons. Studies were performed on the veratridine model in rat brain slices using conventional electrophysiological intracellular techniques. Large concentrations of VPA (5 mM or more) enhanced rather than inhibited epileptiform activity induced by veratridine. During the proepileptic phase of VPA, a membrane depolarization accompanied by a decrease in membrane input resistance were evident. The voltage-dependent proepileptic effect of VPA was blocked by tetrodotoxin (TTX; 100 nM) but not by the calcium channel blockers, diltiazem (5 μM) or ω-conotoxin GVIA (5 μM). VPA did not induce a proepileptic effect when it was superfused at high concentration (0.5–10 mM) on sodium channel-independent models such as the bicuculline or magnesium-free artificial cerebrospinal fluid. Large concentrations of VPA had no significant effect on untreated neurons. The VPA-enhanced veratridine bursting is probably related to the reported proepileptic activities observed in patients taking high doses of this drug. These data also suggest the involvement of sodium channels in the proepileptic effect of VPA.</abstract><cop>Ireland</cop><pub>Elsevier Ireland Ltd</pub><pmid>10617321</pmid><doi>10.1016/S0168-0102(99)00099-1</doi><tpages>9</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0168-0102
ispartof Neuroscience research, 1999-12, Vol.35 (4), p.299-307
issn 0168-0102
1872-8111
language eng
recordid cdi_proquest_miscellaneous_69385497
source MEDLINE; Access via ScienceDirect (Elsevier)
subjects Action Potentials - drug effects
Action Potentials - physiology
Animals
Bicuculline
Bicuculline - pharmacology
Disease Models, Animal
Epilepsy - physiopathology
GABA Antagonists - pharmacology
Hippocampus
Hippocampus - drug effects
Hippocampus - physiopathology
Magnesium-free artificial cerebrospinal fluid (ACSF)
Male
Proepileptic
Pyramidal Cells - drug effects
Pyramidal Cells - physiopathology
Rats
Rats, Sprague-Dawley
Sodium Channels - drug effects
Sodium Channels - physiology
Valproic acid
Valproic Acid - pharmacology
Veratridine
title Valproic acid intensifies epileptiform activity in the hippocampal pyramidal neurons
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-23T18%3A06%3A59IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Valproic%20acid%20intensifies%20epileptiform%20activity%20in%20the%20hippocampal%20pyramidal%20neurons&rft.jtitle=Neuroscience%20research&rft.au=Otoom,%20Sameer%20A&rft.date=1999-12-30&rft.volume=35&rft.issue=4&rft.spage=299&rft.epage=307&rft.pages=299-307&rft.issn=0168-0102&rft.eissn=1872-8111&rft_id=info:doi/10.1016/S0168-0102(99)00099-1&rft_dat=%3Cproquest_cross%3E69385497%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=69385497&rft_id=info:pmid/10617321&rft_els_id=S0168010299000991&rfr_iscdi=true